Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies
Open Access
- 1 June 2015
- journal article
- review article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 8 (6), 509-526
- https://doi.org/10.1242/dmm.020438
Abstract
Mitochondrial diseases are severe and largely untreatable. Owing to the many essential processes carried out by mitochondria and the complex cellular systems that support these processes, these diseases are diverse, pleiotropic, and challenging to study. Much of our current understanding of mitochondrial function and dysfunction comes from studies in the baker's yeast Saccharomyces cerevisiae. Because of its good fermenting capacity, S. cerevisiae can survive mutations that inactivate oxidative phosphorylation, has the ability to tolerate the complete loss of mitochondrial DNA (a property referred to as ‘petite-positivity’), and is amenable to mitochondrial and nuclear genome manipulation. These attributes make it an excellent model system for studying and resolving the molecular basis of numerous mitochondrial diseases. Here, we review the invaluable insights this model organism has yielded about diseases caused by mitochondrial dysfunction, which ranges from primary defects in oxidative phosphorylation to metabolic disorders, as well as dysfunctions in maintaining the genome or in the dynamics of mitochondria. Owing to the high level of functional conservation between yeast and human mitochondrial genes, several yeast species have been instrumental in revealing the molecular mechanisms of pathogenic human mitochondrial gene mutations. Importantly, such insights have pointed to potential therapeutic targets, as have genetic and chemical screens using yeast.Keywords
This publication has 244 references indexed in Scilit:
- Biogenesis of the cytochrome bc1 complex and role of assembly factorsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2012
- Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradationCurrent Opinion in Cell Biology, 2011
- Mitochondrial DNA replication and disease: insights from DNA polymerase γ mutationsCellular and Molecular Life Sciences, 2010
- Consequences of the pathogenic T9176C mutation of human mitochondrial DNA on yeast mitochondrial ATP synthaseBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and functionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Cardiolipin membrane domains in prokaryotes and eukaryotesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- The Mitochondrial Disulfide Relay System Protein GFER Is Mutated in Autosomal-Recessive Myopathy with Cataract and Combined Respiratory-Chain DeficiencyAmerican Journal of Human Genetics, 2009
- Cellular functions of cardiolipin in yeastBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Assembly of F0 in Saccharomyces cerevisiaeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Selective degradation of mitochondria by mitophagyArchives of Biochemistry and Biophysics, 2007